scholarly journals Urinary dysfunction in patients with rectal cancer: a prospective cohort study

2019 ◽  
Vol 22 (1) ◽  
pp. 18-28 ◽  
Author(s):  
L. Karlsson ◽  
D. Bock ◽  
D. Asplund ◽  
B. Ohlsson ◽  
J. Rosenberg ◽  
...  
Author(s):  
Annika Svanström Röjvall ◽  
Christian Buchli ◽  
Angelique Flöter Rådestad ◽  
Anna Martling ◽  
Josefin Segelman

2008 ◽  
Vol 18 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Craig M. Hooker ◽  
Lisa Gallicchio ◽  
Jeanine M. Genkinger ◽  
George W. Comstock ◽  
Anthony J. Alberg

2005 ◽  
Vol 16 (9) ◽  
pp. 1041-1054 ◽  
Author(s):  
Margreet Lüchtenborg ◽  
Matty P. Weijenberg ◽  
Anton F. P. M. de Goeij ◽  
Petra A. Wark ◽  
Mirian Brink ◽  
...  

2017 ◽  
Vol 08 (04) ◽  
pp. 341-348
Author(s):  
Masanori Naito ◽  
Takeo Sato ◽  
Takatoshi Nakamura ◽  
Takahiro Yamanashi ◽  
Hirohisa Miura ◽  
...  

2019 ◽  
Vol 30 ◽  
pp. iv120-iv121
Author(s):  
A. Svanström Röjvall ◽  
C. Buchli ◽  
M. Bottai ◽  
M. Ahlberg ◽  
A. Flöter-Rådestad ◽  
...  

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 3610-3610 ◽  
Author(s):  
Jin Gu ◽  
Changzheng Du ◽  
Ming Li ◽  
Yifan Peng ◽  
Yunfeng Yao ◽  
...  

3610 Background: It has been reported that non-operative treatment (wait and see) is feasible for the selected rectal cancer cases with a complete clinical response (cCR) following neoadjuvant therapy (NT). The aim of this study is to determine whether "wait and see" policy is efficient for the cCR patients in China. Methods: We designed a prospective cohort study in China (ChiCTR-TRC-12002488). From Jul 2012 to August 2016, totally 45 patients with locally advanced rectal cancer who were cCR following NT were enrolled in the study; within whom, 32 patients were assigned to wait and see group, and the remaining 13 patients were assigned to surgery group (intent-to-treat grouping). Results: The median follow-up time was 24 months (range: 3-51). Of the patients who were followed up more than 12 months (n=37), 8 patients developed tumor progression (7 in wait and see group and 1 in surgery group, respectively). In the wait and see group, the local regrowth took an account of 23.1% (6/26), while the distant metastasis rate was 3.8% (1/26). In the surgery group, there were 23.1% (3/13) of patients who has residual cancer confirmed by postoperative pathological assessment. All the patients with tumor regrowth underwent radical surgery and no body died of cancer. Conclusions: Wait and see policy has an acceptable safety and efficiency, it may become an alternative treatment for the patients who were cCR following NT. Clinical trial information: ChiCTR-TRC-12002488. [Table: see text]


2019 ◽  
Vol 107 (5) ◽  
pp. 525-536 ◽  
Author(s):  
A. Svanström Röjvall ◽  
C. Buchli ◽  
M. Bottai ◽  
M. Ahlberg ◽  
A. Flöter-Rådestad ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document